Prognostic Value of Metastatic Tumoral Caveolin-1 Expression in Patients with Resected Gastric Cancer

Table 1

Baseline clinicopathological characteristics of patients with gastric cancer.

Characteristics	No. of patients, n (%)
Patient number	145
Age (years), median	60 (29–89)
>60	73 (50.3)
≤60	72 (49.7)
Gender
Male	107 (73.8)
Female	38 (26.2)
T stage
pT2-3	43 (29.7)
pT4	102 (70.3)
N stage
pN0-1	79 (54.5)
pN2-3	66 (45.5)
TNM stage
I	20 (13.8)
II	44 (30.3)
III	81 (55.9)
Tumor grade
Well	16 (11.0)
Moderate–poor	129 (89.0)
Lymphatic invasion
No	27 (18.8)
Yes	117 (81.2)
Vascular invasion
No	127 (91.4)
Yes	12 (8.6)
Lauren classification
Nondiffuse type	68 (46.9)
Diffuse type	77 (53.1)
LNR, median (range)	0.071 (0-1)
>median	74 (51.0)
≤median	71 (49.0)
Adjuvant therapy
No	70 (48.3)
Yes	75 (51.7)

LNR: lymph node ratio.